Track topics on Twitter Track topics that are important to you
(Reuters) - Abbott Laboratories, which is acquiring St. Jude Medical Inc for $25 billion, reported a quarterly profit that edged past estimates as strength in its medical devices business more than offset a decline in its nutrition unit.
Original Article: Abbott's third-quarter earnings edge past StreetNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...